Neidio i'r cynnwys
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Uwch
  • The effects of disease-modifyi...
  • Dyfynnu hwn
  • Anfonwch hwn fel neges destun
  • E-bostio hwn
  • Argraffu
  • Allforio Cofnod
    • Allforio i RefWorks
    • Allforio i EndNoteWeb
    • Allforio i EndNote
  • Permanent link
The effects of disease-modifying antirheumatic drugs on dementia in patients with rheumatoid arthritis: a population-based propensity-matched cohort study over 15 years

The effects of disease-modifying antirheumatic drugs on dementia in patients with rheumatoid arthritis: a population-based propensity-matched cohort study over 15 years

Manylion Llyfryddiaeth
Prif Awduron: Judge, A, Prieto-Alhambra, D, Arden, N, Cooper, C, Edwards, C
Fformat: Conference item
Cyhoeddwyd: Oxford University Press 2017
  • Daliadau
  • Disgrifiad
  • Eitemau Tebyg
  • Dangos Staff

Eitemau Tebyg

  • Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
    gan: Judge, AD, et al.
    Cyhoeddwyd: (2017)
  • The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis.
    gan: Edwards, C, et al.
    Cyhoeddwyd: (2007)
  • Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines.
    gan: Wallace, G, et al.
    Cyhoeddwyd: (2013)
  • Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
    gan: Emery, P, et al.
    Cyhoeddwyd: (1994)
  • Comparative effectiveness of tumour necrosis factor inhibitor therapy vs. conventional synthetic dmards on need for joint replacement among rheumatoid arthritis patients: A propensity score matched analysis of UK registry data
    gan: Hawley, S, et al.
    Cyhoeddwyd: (2018)

Opsiynau Chwilio

  • Hanes Chwilio
  • Chwiliad Uwch

Canfod Mwy

  • Pori'r Catalog
  • Pori yn ôl y Wyddor
  • Archwiliwch Sianeli
  • Cronfeydd y Cwrs
  • Eitemau Newydd

Angen Help?

  • Awgrymiadau Chwilio
  • Gofynnwch i Lyfrgellydd
  • Cwestiynau Cyffredin